Androgens in the maternal and fetal circulation: association with insulin resistance

References

• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774–800.
   PubMed Web of Science ®Google Scholar
• Falbo A, Rocca M, Russo T, D’Ettore A, Tolino A, Zullo F, Orio F, Palomba S. Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): relationships with adverse outcomes. J Ovarian Res 2010;3:23.
   PubMed Web of Science ®Google Scholar
• Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. BMJ 2011;343:d6309.
   PubMed Web of Science ®Google Scholar
• Feig DS, Zinman B, Wang X, Hux JE. Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 2008;179:229–234.
   PubMed Web of Science ®Google Scholar
• Dyck R, Klomp H, Tan LK, Turnell RW, Boctor MA. A comparison of rates, risk factors, and outcomes of gestational diabetes between aboriginal and non-aboriginal women in the Saskatoon health district. Diabetes Care 2002;25:487–493.
   PubMed Web of Science ®Google Scholar
• Canadian Diabetes Association. Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes 2008;32:S1–S201.
   Web of Science ®Google Scholar
• American diabetes association. Gestational diabetes mellitus. Diabetes Care 2004;27 Suppl 1:S88–S90.
   Google Scholar
• Dokras A, Spaczynski RZ, Behrman HR, Duleba AJ. Testosterone levels in pregnant women correlate with the insulin response during the glucose tolerance test. Fertil Steril 2003;79:492–497.
   PubMed Web of Science ®Google Scholar
• Uzelac PS, Li X, Lin J, Neese LD, Lin L, Nakajima ST, Bohler H, Lei Z. Dysregulation of leptin and testosterone production and their receptor expression in the human placenta with gestational diabetes mellitus. Placenta 2010;31:581–588.
   PubMed Web of Science ®Google Scholar
• Xita N, Tsatsoulis A. Fetal origins of the metabolic syndrome. Ann N Y Acad Sci 2010;1205:148–155.
   PubMed Web of Science ®Google Scholar
• Bruns CM, Baum ST, Colman RJ, Eisner JR, Kemnitz JW, Weindruch R, Abbott DH. Insulin resistance and impaired insulin secretion in prenatally androgenized male rhesus monkeys. J Clin Endocrinol Metab 2004;89:6218–6223.
   PubMed Web of Science ®Google Scholar
• Tsatsoulis A. Developmental programming of polycystic ovary syndrome: Role of prenatal androgen excess. In: Tsatsoulis A, Wyckoff J, Brown FM, editors. Diabetes in women. New York: Humana Press, 2009: 83–103.
   Google Scholar
• Morisset AS, Dubé MC, Côté JA, Robitaille J, Weisnagel SJ, Tchernof A. Circulating interleukin-6 concentrations during and after gestational diabetes mellitus. Acta Obstet Gynecol Scand 2011;90:524–530.
   PubMed Web of Science ®Google Scholar
• Morisset AS, Dubé MC, Drolet R, Robitaille J, Weisnagel SJ, Tchernof A. Sex hormone-binding globulin levels and obesity in women with gestational diabetes: relationship with infant birthweight. Gynecol Endocrinol 2011;27:905–909.
   PubMed Web of Science ®Google Scholar
• Dubé MC, Girard M, Morisset AS, Tchernof A, Weisnagel SJ, Bujold E. Evaluation of fetal liver volume by tridimensional ultrasound in women with gestational diabetes mellitus. J Obstet Gynaecol Can 2011;33:1095–1098.
   PubMedGoogle Scholar
• Dubé MC, Morisset AS, Tchernof A, Weisnagel SJ. Impact of a mother’s weight history on her offspring. J Obstet Gynaecol Can 2012;34:34–38.
   Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–419.
   PubMed Web of Science ®Google Scholar
• Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462–1470.
   PubMed Web of Science ®Google Scholar
• Piché ME, Arcand-Bossé JF, Després JP, Pérusse L, Lemieux S, Weisnagel SJ. What is a normal glucose value? Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose. Diabetes Care 2004;27:2470–2477.
   PubMed Web of Science ®Google Scholar
• Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, et al. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol 2006;99:182–188.
   PubMed Web of Science ®Google Scholar
• Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, et al. Metabolism of DHEA in postmenopausal women following percutaneous administration. J Steroid Biochem Mol Biol 2007;103:178–188.
   PubMed Web of Science ®Google Scholar
• Simmons D, France JT, Keelan JA, Song L, Knox BS. Sex differences in umbilical cord serum levels of inhibin, testosterone, oestradiol, dehydroepiandrosterone sulphate, and sex hormone-binding globulin in human term neonates. Biol Neonate 1994;65:287–294.
   PubMedGoogle Scholar
• Troisi R, Potischman N, Roberts J, Siiteri P, Daftary A, Sims C, Hoover RN. Associations of maternal and umbilical cord hormone concentrations with maternal, gestational and neonatal factors (United States). Cancer Causes Control 2003;14:347–355.
   PubMed Web of Science ®Google Scholar
• Gemer O, Sevillia J, Zalis J, Segal S. Umbilical cord androgens in infants of diabetic mothers. Arch Gynecol Obstet 1997;259:139–141.
   Google Scholar
• Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007;92:405–413.
   PubMed Web of Science ®Google Scholar
• Nestler JE. Insulin and insulin-like growth factor-I stimulate the 3 beta-hydroxysteroid dehydrogenase activity of human placental cytotrophoblasts. Endocrinology 1989;125:2127–2133.
   PubMed Web of Science ®Google Scholar
• Nestler JE. Insulin-like growth factor II is a potent inhibitor of the aromatase activity of human placental cytotrophoblasts. Endocrinology 1990;127:2064–2070.
   PubMed Web of Science ®Google Scholar
• Nestler JE. Modulation of aromatase and P450 cholesterol side-chain cleavage enzyme activities of human placental cytotrophoblasts by insulin and insulin-like growth factor I. Endocrinology 1987;121:1845–1852.
   PubMed Web of Science ®Google Scholar
• Taricco E, Radaelli T, Nobile de Santis MS, Cetin I. Foetal and placental weights in relation to maternal characteristics in gestational diabetes. Placenta 2003;24:343–347.
   PubMed Web of Science ®Google Scholar